Sign in
8-K

Current Report

NextCure, Inc. Filed Acc 0001104659-26-083326

Material agreement · Exit or restructuring costs · Change in control · Executive or director change · Regulation FD disclosure · Other events

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.05 Costs associated with exit or disposal activities
  • Item 5.01 Changes in control of the registrant
  • Item 5.02 Departure or appointment of directors or officers
  • Item 7.01 Regulation FD disclosure
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading tm2620428d1_8k.htm…